Pharmacokinetic profiles of significant adverse events with crizotinib in Japanese patients with ABCB1 polymorphism

about

Paclitaxel-induced sensory peripheral neuropathy is associated with an ABCB1 single nucleotide polymorphism and older age in Japanese.First-line alectinib for ALK-positive lung cancer: is there room for further improvement?

P2860

Q38817753-8DB4AFEE-E163-4F01-9A03-B78CB4796787 Q55712374-D3C08ED6-4B0E-4E28-9370-6C82CD300811

P2860

Pharmacokinetic profiles of significant adverse events with crizotinib in Japanese patients with ABCB1 polymorphism

Item

http://www.wikidata.org/entity/Q37170724

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 06 June 2016

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Pharmacokinetic profiles of si ...... tients with ABCB1 polymorphism

@en

Pharmacokinetic profiles of si ...... ients with ABCB1 polymorphism.

@nl

type

Item

label

Pharmacokinetic profiles of si ...... tients with ABCB1 polymorphism

@en

Pharmacokinetic profiles of si ...... ients with ABCB1 polymorphism.

@nl

prefLabel

Pharmacokinetic profiles of si ...... tients with ABCB1 polymorphism

@en

Pharmacokinetic profiles of si ...... ients with ABCB1 polymorphism.

@nl

P1476

Pharmacokinetic profiles of si ...... tients with ABCB1 polymorphism

@en

P2093

Akinobu Hamada

http://www.w3.org/2001/XMLSchema#string

Hidehito Horinouchi

http://www.w3.org/2001/XMLSchema#string

Hidenori Mizugaki

http://www.w3.org/2001/XMLSchema#string

Hiroaki Aikawa

http://www.w3.org/2001/XMLSchema#string

Hiroshi Nokihara

http://www.w3.org/2001/XMLSchema#string

Kota Itahashi

http://www.w3.org/2001/XMLSchema#string

Noboru Yamamoto

http://www.w3.org/2001/XMLSchema#string

Shintaro Kanda

http://www.w3.org/2001/XMLSchema#string

Toshiyuki Hata

http://www.w3.org/2001/XMLSchema#string

Yasushi Goto

http://www.w3.org/2001/XMLSchema#string

P2860

Identification of the transforming EML4-ALK fusion gene in non-small-cell lung cancer.

Anaplastic lymphoma kinase inhibition in non-small-cell lung cancer.

Effect of crizotinib on overall survival in patients with advanced non-small-cell lung cancer harbouring ALK gene rearrangement: a retrospective analysis

Crizotinib versus chemotherapy in advanced ALK-positive lung cancer.

Crizotinib in ROS1-rearranged non-small-cell lung cancer.

First-line crizotinib versus chemotherapy in ALK-positive lung cancer.

Response to MET inhibitors in patients with stage IV lung adenocarcinomas harboring MET mutations causing exon 14 skipping

New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada

A synonymous polymorphism in a common MDR1 (ABCB1) haplotype shapes protein function.

Using multiplexed assays of oncogenic drivers in lung cancers to select targeted drugs.

P304

1117-1123

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/CAS.12983

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

107

http://www.w3.org/2001/XMLSchema#string

P50

Yutaka Fujiwara

P577

2016-07-21T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27270784

http://www.w3.org/2001/XMLSchema#string

P921

crizotinib

P932

4982581

http://www.w3.org/2001/XMLSchema#string

Pharmacokinetic profiles of significant adverse events with crizotinib in Japanese patients with ABCB1 polymorphism

about

P2860

P2860

Pharmacokinetic profiles of significant adverse events with crizotinib in Japanese patients with ABCB1 polymorphism

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P921

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P921

P932